May 26, 2009 - Sectra’s net sales increased by 16.2 percent to SEK 863.3 million (742.9) compared with the preceding fiscal year. The Group’s order bookings rose 13.1 percent to SEK 1,149.7 million (1,016.6). Profit after financial items was SEK 71.4 million (79.8), corresponding to profit margin of 8.3 percent (10.7).

During the fourth quarter, Sectra’s net sales rose 17.5 percent to SEK 263.7 million (224.5). Profit after financial items amounted to SEK 7.4 million (42.3), corresponding to a profit margin of 2.8 percent (18.9). Order bookings increased 31.2 percent to SEK 207.7 million (158.3).
“A limited number of large, long-term customer projects have resulted in initial costs for the group that affected the profit margin adversely. Profit was also adversely impacted by the continued expansion of distribution channels and increase in production capacity in the mammography area,” said Jan-Olof Brüer, president and CEO of Sectra AB.
The international expansion continued and markets outside Sweden accounted for 70.2 percent (66.8) of the group’s sales during the year.
“The Medical Systems business area continued to expand during the 2008/2009 fiscal year despite weaker economic conditions worldwide. Within the business area, the mammography product division experienced the greatest growth during the 2008/2009 fiscal year, increasing 50 percent,” indicated Brüer.

For more information: www.sectra.se


Related Content

News | Women's Health

March 4, 2026 — QT Imaging Holdings recently announced that Mary W. Yamashita, MD will serve as medical advisor to the ...

Time March 06, 2026
arrow
News | Artificial Intelligence

March 2, 2026 — RadNet, Inc. has acquired Gleamer SAS, a radiology AI company based in Paris, France. Gleamer will be ...

Time March 03, 2026
arrow
News | Women's Health

Feb.23, 2026 — The first clinical patient received a Clairity Breast cancer risk score, marking a historic milestone in ...

Time February 23, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — VizMark has received U.S. Food and Drug Administration FDA 510k clearance for VM1, a non-metal visual ...

Time January 19, 2026
arrow
News | Women's Health

Dec. 12. 2025 — A new study has found that an individualized approach to breast cancer screening that assesses patients’ ...

Time December 17, 2025
arrow
News | Breast Imaging

Dec. 16, 2025 — Hologic, Inc, a medical technology company dedicated to improving women’s health, recently announced new ...

Time December 16, 2025
arrow
News | FDA

Dec. 8, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, has submitted a 510(k) premarket ...

Time December 08, 2025
arrow
News | Breast Imaging

Dec. 01, 2025 — DeepHealth, a wholly owned subsidiary of RadNet, Inc., has launched the DeepHealth Breast Suite,2 an end ...

Time December 04, 2025
arrow
News | Women's Health

Dec. 1, 2025 — A study of data from seven outpatient facilities in the New York region found that 20-24% of all the ...

Time December 02, 2025
arrow
Subscribe Now